Orthopedic Alerts for Patients - Implant Recalls

Alerts and implant recalls for patients with orthopedic bone and joint conditions.

In response to a staggering decline in sales and a recent U.S. Food and Drug Administration (FDA) proposal to tighten regulations on all-metal hip implants, Johnson & Johnson has opted to halt the sale of its metal-on-metal products. DePuy Orthopaedics, a division of Johnson & Johnson, will stop worldwide sales of its Ultamet Metal-on-Metal Articulation [...]

Read more ...

Thousands of American women fighting to get their voices heard and draw awareness to the life-changing complications of transvaginal mesh are not alone. The problems surrounding these controversial implants affect women on a global scale, and victims and their families are banding together to support one another and draw attention to the issue. Transvaginal mesh [...]

Read more ...

An estimated 100 patients filed a federal lawsuit against Medtronic­ – the maker of the INFUSE Bone Graft – and a spinal surgeon who patients say performed experimental spine surgery without consent, Mass Device reported. In their claim, former patients said Dr. Abubakar Atiq Durrani “performed medically unnecessary, experimental spine surgeries … using falsely and [...]

Read more ...

Researchers in Japan have developed a new blood test that may hold promise for catching pancreatic cancer early enough to improve patient survival. That could be good news for diabetes patients, who may be at an increased risk of developing pancreatic cancer if they take certain medications, including Januvia and Byetta. The new screening method [...]

Read more ...

An Illinois jury ruled in favor of Johnson & Johnson in the second trial alleging that defects in the DePuy ASR hip implant caused the device to fail at unacceptably high rates. DePuy Orthopaedics, a division of Johnson & Johnson, issued a voluntary recall for the ASR XL Acetabular Hip System in August 2010. The [...]

Read more ...

Hip implant recalls cost orthopaedic manufacturing companies Stryker and Johnson & Johnson millions of dollars so far in 2013, according to first-quarter earnings reports by the companies. Stryker Corporation’s report of quarterly net earnings includes a $40 million charge related to the 2012 voluntary recall of its Rejuvenate and ABG II Modular-Neck Hip Stems, hiking [...]

Read more ...

The U.S. Food and Drug Administration (FDA) will take a second look at a key study defending the safety of Avandia, a former blockbuster diabetes drug the agency tightly restricted in 2010 over heart risk concerns. The 2009 study, known as the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Diabetes (RECORD) trial, was sponsored [...]

Read more ...

The use of antidepressants during pregnancy increases the risk of autism spectrum disorders in children, according to a Swedish study. The New York Times reported on the study that collected data from the Swedish medical birth register and other publicly funded sources that screen for autism spectrum disorders. The researchers also took other factors linked [...]

Read more ...

Drinking an energy drink may have the same artery-hardening effects as eating a porterhouse steak. A nutrient found in red meat and used in energy drinks and weight loss pills contributes to hardening of the arteries, according to researchers at the Cleveland Clinic. According to the new findings, cholesterol levels alone might not be the [...]

Read more ...